- Drug Class
- Acetylcholinesterase Inhibitor
- Mechanism of Action (MOA)
- Inhibits central acetylcholinesterase → ↑ synaptic acetylcholine.
- Clinical Notes
- Symptomatic Alzheimer dementia (modest, not disease-modifying). Cholinergic effects: bradycardia/syncope, GI upset, vivid dreams.
Sources
Reviewed June 2026- FDA label — FDA / DailyMed
Checked against the guideline or standard reference the exam keys to. If it has moved, use Report an error below.
All pharmacology